Quanterix Corporation Financing Cash Flow
Quanterix Corporation (QTRX) reported Financing Cash Flow of -$1.30 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-10
- Quanterix Corporation net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was -$527.00K.
- Quanterix Corporation net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$770.00K, a 927.96% decline year-over-year.
- Quanterix Corporation net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was -$522.00K, a 1373.17% decline year-over-year.
- Quanterix Corporation net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $150.00K, a 4.17% increase year-over-year.
- Quanterix Corporation net cash provided by (used in) financing activities for fiscal 2025 was -$708.00K, a 255.26% decline from fiscal 2024.
- Quanterix Corporation net cash provided by (used in) financing activities for fiscal 2024 was $456.00K, a 83.05% decline from fiscal 2023.
- Quanterix Corporation net cash provided by (used in) financing activities for fiscal 2023 was $2.69M, a 16.44% increase from fiscal 2022.
- Quanterix Corporation net cash provided by (used in) financing activities for fiscal 2022 was $2.31M, a 99.15% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$527.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$1.30M 10-Q · filed 2026-08-10 | -$1.82M derived: sum of 3 quarters · filed 2026-08-10 | -$1.67M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | -$770.00K 10-Q · filed 2026-05-06 | -$1.29M derived: sum of 2 quarters · filed 2026-05-06 | -$1.14M derived: sum of 3 quarters · filed 2026-05-06 | -$1.57M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | -$522.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$372.00K derived: sum of 2 quarters · filed 2026-03-02 | -$801.00K derived: sum of 3 quarters · filed 2026-08-10 | -$708.00K 10-K · filed 2026-03-02 |
| 2025-09-30 | $150.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$279.00K derived: sum of 2 quarters · filed 2026-08-10 | -$186.00K 10-Q · filed 2025-11-10 | -$145.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | -$429.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$336.00K 10-Q · filed 2026-08-10 | -$295.00K derived: sum of 3 quarters · filed 2026-08-10 | -$151.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $93.00K 10-Q · filed 2026-05-06 | $134.00K derived: sum of 2 quarters · filed 2026-05-06 | $278.00K derived: sum of 3 quarters · filed 2026-05-06 | -$50.00K derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $41.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $185.00K derived: sum of 2 quarters · filed 2026-03-02 | -$143.00K derived: sum of 3 quarters · filed 2026-03-02 | $456.00K 10-K · filed 2026-03-02 |
| 2024-09-30 | $144.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$184.00K derived: sum of 2 quarters · filed 2025-11-10 | $415.00K 10-Q · filed 2025-11-10 | $616.00K derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-06-30 | -$328.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $271.00K 10-Q · filed 2025-08-07 | $472.00K derived: sum of 3 quarters · filed 2026-03-02 | $2.27M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-03-31 | $599.00K 10-Q · filed 2025-05-12 | $800.00K derived: sum of 2 quarters · filed 2026-03-02 | $2.60M derived: sum of 3 quarters · filed 2026-03-02 | $2.74M derived: sum of 4 quarters · filed 2026-03-02 |
| 2023-12-31 | $201.00K derived: 10-K 12 month − 10-K/A 9 month · filed 2026-03-02 | $2.00M derived: sum of 2 quarters · filed 2026-03-02 | $2.14M derived: sum of 3 quarters · filed 2026-03-02 | $2.69M 10-K · filed 2026-03-02 |
| 2023-09-30 | $1.80M derived: 10-K/A 9 month − 10-K/A 6 month · filed 2024-12-26 | $1.94M derived: sum of 2 quarters · filed 2024-12-26 | $2.49M 10-K/A · filed 2024-12-26 | $3.20M derived: sum of 4 quarters · filed 2025-03-17 |
| 2023-06-30 | $139.00K derived: 10-K/A 6 month − 10-K/A 3 month · filed 2024-12-26 | $690.00K 10-K/A · filed 2024-12-26 | $1.40M derived: sum of 3 quarters · filed 2025-03-17 | $1.81M derived: sum of 4 quarters · filed 2025-03-17 |
| 2023-03-31 | $551.00K 10-K/A · filed 2024-12-26 | $1.26M derived: sum of 2 quarters · filed 2025-03-17 | $1.67M derived: sum of 3 quarters · filed 2025-03-17 | $1.88M derived: sum of 4 quarters · filed 2025-03-17 |
| 2022-12-31 | $714.00K derived: 10-K 12 month − 10-K/A 9 month · filed 2025-03-17 | $1.12M derived: sum of 2 quarters · filed 2025-03-17 | $1.33M derived: sum of 3 quarters · filed 2025-03-17 | $2.31M 10-K · filed 2025-03-17 |
| 2022-09-30 | $407.00K derived: 10-K/A 9 month − 10-K/A 6 month · filed 2024-12-26 | $618.00K derived: sum of 2 quarters · filed 2024-12-26 | $1.60M 10-K/A · filed 2024-12-26 | $746.00K derived: sum of 4 quarters · filed 2024-12-26 |
| 2022-06-30 | $211.00K derived: 10-K/A 6 month − 10-K/A 3 month · filed 2024-12-26 | $1.19M 10-K/A · filed 2024-12-26 | $339.00K derived: sum of 3 quarters · filed 2024-12-26 | -$3.72M derived: sum of 4 quarters · filed 2024-12-26 |
| 2022-03-31 | $979.00K 10-K/A · filed 2024-12-26 | $128.00K derived: sum of 2 quarters · filed 2024-12-26 | -$3.93M derived: sum of 3 quarters · filed 2024-12-26 | -$1.54M derived: sum of 4 quarters · filed 2024-12-26 |
| 2021-12-31 | -$851.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-12-26 | -$4.91M derived: sum of 2 quarters · filed 2024-12-26 | -$2.52M derived: sum of 3 quarters · filed 2024-12-26 | $270.80M 10-K/A · filed 2024-12-26 |
| 2021-09-30 | -$4.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$1.67M derived: sum of 2 quarters · filed 2022-11-09 | $271.65M 10-Q · filed 2022-11-09 | $273.72M derived: sum of 4 quarters · filed 2023-03-06 |
| 2021-06-30 | $2.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $275.71M 10-Q · filed 2022-08-08 | $277.78M derived: sum of 3 quarters · filed 2023-03-06 | $370.47M derived: sum of 4 quarters · filed 2023-03-06 |
| 2021-03-31 | $273.31M 10-Q · filed 2022-05-10 | $275.39M derived: sum of 2 quarters · filed 2023-03-06 | $368.07M derived: sum of 3 quarters · filed 2023-03-06 | $368.69M derived: sum of 4 quarters · filed 2023-03-06 |
| 2020-12-31 | $2.08M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $94.76M derived: sum of 2 quarters · filed 2023-03-06 | $95.38M derived: sum of 3 quarters · filed 2023-03-06 | $96.24M 10-K · filed 2023-03-06 |
| 2020-09-30 | $92.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $93.30M derived: sum of 2 quarters · filed 2021-11-04 | $94.16M 10-Q · filed 2021-11-04 | $94.88M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $615.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $1.48M 10-Q · filed 2021-08-05 | $2.20M derived: sum of 3 quarters · filed 2022-03-01 | $67.40M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $861.00K 10-Q · filed 2021-05-06 | $1.58M derived: sum of 2 quarters · filed 2022-03-01 | $66.79M derived: sum of 3 quarters · filed 2022-03-01 | $116.23M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $724.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $65.92M derived: sum of 2 quarters · filed 2022-03-01 | $115.37M derived: sum of 3 quarters · filed 2022-03-01 | $116.20M 10-K · filed 2022-03-01 |
| 2019-09-30 | $65.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $114.64M derived: sum of 2 quarters · filed 2020-11-06 | $115.47M 10-Q · filed 2020-11-06 | $116.69M derived: sum of 4 quarters · filed 2021-03-05 |
| 2019-06-30 | $49.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $50.27M 10-Q · filed 2020-08-04 | $51.49M derived: sum of 3 quarters · filed 2021-03-05 | $51.74M derived: sum of 4 quarters · filed 2021-03-05 |
| 2019-03-31 | $831.00K 10-Q · filed 2020-05-07 | $2.05M derived: sum of 2 quarters · filed 2021-03-05 | $2.30M derived: sum of 3 quarters · filed 2021-03-05 | $1.69M derived: sum of 4 quarters · filed 2021-03-05 |
| 2018-12-31 | $1.22M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-05 | $1.47M derived: sum of 2 quarters · filed 2021-03-05 | $863.00K derived: sum of 3 quarters · filed 2021-03-05 | -$78.00K 10-K · filed 2021-03-05 |
| 2018-09-30 | $248.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | -$358.00K derived: sum of 2 quarters · filed 2019-11-08 | -$1.30M 10-Q · filed 2019-11-08 | $64.43M derived: sum of 4 quarters · filed 2020-03-13 |
| 2018-06-30 | -$606.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | -$1.55M 10-Q · filed 2019-08-06 | $64.19M derived: sum of 3 quarters · filed 2020-03-13 | $64.20M derived: sum of 4 quarters · filed 2020-03-13 |
| 2018-03-31 | -$941.00K 10-Q · filed 2019-05-10 | $64.79M derived: sum of 2 quarters · filed 2020-03-13 | $64.80M derived: sum of 3 quarters · filed 2020-03-13 | $73.26M derived: sum of 4 quarters · filed 2020-03-13 |
| 2017-12-31 | $65.73M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $65.75M derived: sum of 2 quarters · filed 2020-03-13 | $74.20M derived: sum of 3 quarters · filed 2020-03-13 | $73.25M 10-K · filed 2020-03-13 |
| 2017-09-30 | $12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $8.46M derived: sum of 2 quarters · filed 2018-11-07 | $7.52M 10-Q · filed 2018-11-07 | |
| 2017-06-30 | $8.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | $7.50M 10-Q · filed 2018-08-10 | ||
| 2017-03-31 | -$949.00K 10-Q · filed 2018-05-15 | |||
| 2016-12-31 | $45.92M 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |